MPH Health Care AG
XETRA:93M1
MPH Health Care AG
Revenue
MPH Health Care AG
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MPH Health Care AG
XETRA:93M1
|
Revenue
€37.4k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Revenue
$314k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bayer AG
XETRA:BAYN
|
Revenue
€47.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
Merck KGaA
XETRA:MRK
|
Revenue
€21B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Dermapharm Holding SE
XETRA:DMP
|
Revenue
€1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Revenue
€85.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is MPH Health Care AG's Revenue?
Revenue
37.4k
EUR
Based on the financial report for Dec 31, 2022, MPH Health Care AG's Revenue amounts to 37.4k EUR.
What is MPH Health Care AG's Revenue growth rate?
Revenue CAGR 5Y
-39%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for MPH Health Care AG have been -5% over the past three years , -39% over the past five years .